NASDAQ
BioMark Diagnostics Inc. (BMKDF) has a free cash flow growth of -66.81% as of Friday, May 29, 2026. This represents a 22.63% decrease compared to its 12-month average of -54.48%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.